Ligand Pharmaceuticals Inc Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 38.94M23.54M30.04M31.39M48.97M64.54M71.91M108.97M141.10M251.45M120.28M163.56M241.54M196.25M131.31M167.13M
Cost of Revenue 4.91M3.60M5.73M9.14M5.81M5.57M5.37M6.34M11.35M30.42M62.18M52.83M10.51M11.07M
Gross Profit 38.94M23.54M25.13M27.79M43.24M55.40M66.11M103.40M135.74M245.12M108.94M133.14M179.37M143.42M120.80M156.06M
Operating items
Amortization - Intangibles 2.38M2.38M10.64M12.12M15.79M16.86M11.64M34.22M34.24M33.70M33.00M
Research & Development 39.87M22.07M10.29M10.79M9.27M9.75M11.01M21.22M26.89M27.86M55.91M40.50M32.10M36.08M24.54M21.43M
Selling, General & Administrative 15.21M12.83M14.58M15.78M17.98M22.57M25.40M27.65M28.65M37.73M41.88M60.01M46.79M70.06M52.79M78.65M
Restructuring Costs 0.55M1.02M0.56M1.08M1.02M1.03M
Other Operating Expenses 15.68M19.65M7.19M3.60M6.21M11.51M7.16M15.18M17.49M22.13M812.80M-0.60M37.60M87.06M2.12M89.66M
Operating Expenses 70.76M54.54M32.62M31.20M34.03M44.91M44.59M65.09M73.03M87.73M126.00M143.18M137.69M193.21M121.49M189.74M
Operating Income -9.97M-29.30M-0.88M0.19M14.94M19.63M27.33M43.88M68.08M163.73M807.08M37.50M103.85M3.04M11.94M-22.61M
EBIT -9.97M-29.30M-0.88M0.19M14.94M19.63M27.33M43.88M68.08M163.73M807.08M37.50M103.85M3.04M11.94M-22.61M
Non-operating items
Non Operating Investment Income -2.05M50.38M1.05M-16.93M-5.26M28.54M46.37M75.02M
Interest & Investment Income 0.59M0.44M0.03M0.66M2.06M14.00M28.43M8.08M0.89M2.05M7.71M8.05M
Other Non Operating Income -0.22M4.38M0.63M0.52M-0.06M1.67M1.77M-0.61M2.60M-6.50M-4.17M0.06M-7.65M4.19M-1.70M-54.92M
Non Operating Income -0.22M13.90M-2.68M-4.06M-5.74M-8.32M8.00M-35.92M-10.85M9.60M-10.44M-36.21M-31.65M32.97M51.72M-54.92M
Net income details
EBT -9.87M-15.40M-3.56M-3.87M9.21M11.30M35.33M7.96M57.23M173.33M796.64M1.29M72.20M36.01M63.66M2.52M
Tax Provisions -1.53M-2.62M-13.27M-1.19M0.37M0.41M-192.12M10.33M44.67M30.01M167.34M-5.31M-4.15M41.23M9.84M6.55M
Profit After Tax -8.34M-12.79M9.71M-2.67M11.42M12.02M229.82M-2.37M12.56M143.32M629.30M6.60M76.35M-33.36M53.82M-4.03M
Equity Income -5.14M-23.13M1.11M47.66M2.89M
Net Income - Minority 1.91M
Income from Non-Controlling Interests -1.13M2.38M
Income from Continuing Operations -8.34M-12.79M9.71M-2.67M8.83M10.89M227.44M-2.37M12.56M143.32M629.30M6.60M76.35M-5.22M53.82M-4.03M
Consolidated Net Income 6.39M2.41M0.00M3.66M2.59M10.89M227.44M0.73M12.56M143.32M629.30M-9.58M-19.21M-28.14M-1.67M-4.03M
Income towards Parent Company 6.39M2.41M0.00M3.66M2.59M12.80M227.44M0.73M12.56M143.32M629.30M-9.58M-19.21M-28.14M-1.67M-4.03M
Net Income towards Common Stockholders 6.39M2.41M0.00M3.66M2.59M12.80M227.44M0.73M12.56M143.32M629.30M-9.58M-19.21M-28.14M-1.67M-4.03M
Additional items
EPS (Basic) -0.00M-0.00M0.00M-0.00M0.00M0.00M0.00M-0.00M0.00M0.00M0.00M0.00M0.00M-0.00M0.00M-0.00M
EPS (Weighted Average and Diluted) 0.00M0.00M0.00M-0.00M0.00M0.00M0.00M-0.00M0.00M0.00M0.00M0.00M0.00M-0.00M0.00M-0.00M
Shares Outstanding (Weighted Average) 18.84M19.61M19.67M19.96M20.41M20.02M19.93M20.90M21.11M21.25M17.56M16.09M16.71M16.89M17.44M18.90M
Shares Outstanding (Diluted Average) 18.86M19.61M19.71M19.85M20.75M21.43M21.23M20.83M23.48M24.07M19.76M16.82M17.25M16.87M17.76M18.29M
EBITDA -9.97M-29.30M-0.88M0.19M14.94M19.63M27.33M43.88M68.08M163.73M807.08M37.50M103.85M3.04M11.94M-22.61M
Tax Rate 15.55%16.99%30.82%4.06%3.63%78.06%17.31%21.01%15.46%